Featured post

Hombale Films and Prabhas all set to join forces for three mega films, set to

 *Hombale Films and Prabhas all set to join forces for three mega films, set to redefine entertainment on the big screens!*   In an unpreced...

Friday 29 April 2022

Tamil Moj creators shake a leg with superstars Ashwin Kumar and Losliya

Tamil Moj creators shake a leg with superstars Ashwin Kumar and Losliya Mariyanesan on the popular track Baby Nee Sugar In collaboration with Sony Music South, 13 Moj creators were given the opportunity to recreate the hook dance of

Baby Nee Sugar alongside celebrities

Moj, India’s number one short-video platform, recently collaborated with Sony Music South and prominent Kollywood stars Ashwin Kumar,Losliya Mariyanesan, who just released their single "Baby Nee Sugar." 13 popular Tamil Moj creators, including Niharikka Ranjith, Darwin Spiritoe, Manikanan K, and Gracy, were given the opportunity to record the hook step with Ashwin and Losliya that is now live on Moj.

The peppy beats of the track had the creators dancing their hearts out and the catchy vibe of the song created a storm on the platform. The creators' content has been well received, and viewers are recreating their own versions in a variety of genres. Apart from recording the hook step with the popular actors, the aspiring creators had the opportunity to meet and interact with the charming duo Losliya Mariyanesan and Ashwin Kumar. From collaborating with big studio films to featuring in music videos, Moj is known for providing a platform for all talented creators from all over India. This collaboration, in turn, provides multiple avenues for creators to gain recognition and monetise their effort.

The Moj creators learned several tips and tricks around creative content creation from the stars. Moj created another one-of-a-kind opportunity for aspiring talented artists with this collaboration. Moj intends to launch additional programs to encourage and empower the talented youth of Tamil Nadu to create high-quality content on the platform. Moj is continuously on the cutting edge of providing the best opportunities to its creators.

Regarding the collaboration with Moj creators, popular sensation Losliya Mariyanesan and Ashwin Kumar said,” The entertainment industry is continuously evolving, and the chance to work with up-and-coming and creative Moj creators on our most recent single, Baby Nee Sugar, was quite refreshing. As creators, We understand the hardships of brilliant young people that work tirelessly day in and day out to achieve their goals. Such opportunities assist individuals in evolving and hastening their path. We had a terrific time working with the Moj creators and were able to share our knowledge and experience with them. We are in awe of their talent and wish them the best of luck in their future endeavors."

 

Moj creator Darwin Spiritoe said,” I had a great time working with Ashwin and Losliya for this initiative. They were fantastic role models for us. They not only recreated the hook step with us, but they also gave some amazing ideas and tactics to help us improve our content creation skills. I'd like to thank Moj for giving us such life-changing opportunities and their unwavering support as we showcase our ability and skills to the world. #BabyNeeSugar offered an excellent opportunity for all of us to learn more and improve our content creation expertise. I hope to have many more opportunities like this."

 

This was an incredible opportunity for all of the aspiring creators to come together and create collaborative and entertaining content with superstars in Tamil. So, if you want to start your creator journey, learn from some of the top creators in their field, and network with other ambitious creators, simply join the Moj For Creators program and get the rewards.

 

Here is a glimpse of the content the creators created at the event -

https://mojapp.in/@kalai_dance_academy/video/2493328521?referrer=T2EVIFv-gLjVCX

https://mojapp.in/@grace_dimple_queen/video/2494737522?referrer=T2EVNLM-gLjVCX

https://mojapp.in/@ijazactor/video/2493468863?referrer=T2EVPiS-gLjVCX

https://mojapp.in/@swesuresh2000/video/2493323619?referrer=T2EVSrp-gLjVCX

https://mojapp.in/@g_niee_sagar/video/2493345038?referrer=T2EVVvC-gLjVCX

https://mojapp.in/@sonymusic_south/video/2495709096?referrer=T2EVsHf-gLjVCX

https://mojapp.in/@sonymusic_south/video/2495283636?referrer=T2EVxbN-gLjVCX

 

 

Much Expected Director Mysskin's Pisasu2

Much Expected @DirectorMysskin's #Pisasu2 | #Pisachi2 | #Pishaachi2 | #Pishaachi2 Teaser to be released by Actor, Music Director, Producer @vijayantony by 5PM Today

Get ready to be Horrified ЁЯзЯ‍♀️ЁЯзЯ‍♂️



@Rockfortent @andrea_jeremiah @VijaySethuOffl @Lv_Sri @actor_ajmal @shamna_kkasim @Actorsanthosh @kbsriram16 @APVMaran @saregamasouth @teamaimpr


Coromandel International posts Q4 and Full Year Results

Coromandel International posts Q4 and Full Year Results

 

Coromandel International Limited (BSE: 506395, NSE: COROMANDEL), India's leading Agri solutions provider is in the business of Fertilisers, Crop Protection, Bio pesticides, Specialty Nutrients, Organic Fertiliser and Retail. The Company has reported the financial results for the quarter and year ended 31st March 2022.

 

The Board of Directors of Coromandel International Limited has approved the financial results of the Company for the quarter and year ended 31st March 2022. The Board had declared an interim dividend of Rs. 6.00 per share in February 2022 and was paid to the shareholders in March 2022. The Board has now recommended a final dividend of Rs. 6 per share for the financial year 2021-22.

 

Highlight : Standalone Results:

 

       Total Income in Q4 was at Rs. 4,294 Cr compared with Rs. 2,860 Cr of same period previous year, registering a growth of 50% over previous year.

       EBITDA for Q4 was Rs. 272 Cr registering an increase of 20% over Q4 of previous year.

       PAT for Q4 was Rs. 183 Cr vs Rs. 156 Cr in Q4 of previous year registering a y/y growth of 17%

       Total Income for the year ended 31st March 2022 was Rs. 19,231 Cr compared with Rs. 14,231 Cr of same period previous year, registering a growth of 35% over previous year.

       EBITDA for FY 21-22 was Rs. 2,036 Cr vs. Rs. 1,970 Cr in previous year, registering an increase of 3% over previous year.

       PAT for FY 21-22 was Rs. 1,412 Cr vs Rs. 1,313 Cr of previous year registering a y/y growth of 8%.

 

Review of Businesses

 

Nutrient and other allied business

The Revenue for the quarter was at Rs. 3,683 Cr compared with Rs. 2,344 Cr in the corresponding quarter of the previous year, registering a y/y growth of 57%. Segment result for the quarter was Rs. 222 Cr as against Rs. 169 Cr in the corresponding quarter of the previous year.

The Revenue for FY 21-22 grew by 37% to Rs. 16,714 Cr compared with Rs. 12,200 Cr in the corresponding period of the previous year. Segment result for FY 21-22 was Rs. 1,671 Cr as against Rs. 1,653 Cr in the corresponding period of the previous year.

 

Crop protection business

The Revenue for the quarter grew by 11% compared to same quarter previous year at Rs. 547 Cr vs. Rs. 494 Cr during the previous year. Segment result for the quarter was Rs. 68 Cr compared with Rs. 62 Cr in the corresponding quarter of the previous year.

The Revenue for FY 21-22 grew by 21% to Rs. 2,488 Cr compared with Rs. 2,058 Cr in the corresponding period of the previous year. Segment result for FY 21-22 was Rs. 357 Cr as against Rs. 333 Cr in the corresponding period of the previous year.


 Consolidated Results

Coromandel’s total income for the quarter was at Rs. 4,304 Cr as against Rs. 2,872 Cr in the corresponding quarter of the previous year. The profit after tax for the quarter was at Rs. 290 Cr as against Rs. 156 Cr in the corresponding quarter of the previous year.

Coromandel’s total income for FY 21-22 was at Rs. 19,255 Cr as against Rs. 14,257 Cr in the corresponding period of the previous year. The profit after tax was at Rs. 1,528 Cr as against Rs. 1,329 Cr in the previous year.




 Commenting on the financial results, Mr. Sameer Goel, Managing Director, Coromandel International Ltd. said

“During the financial year 2021-22, Agri sector registered a strong performance with record food grain production and agri-exports. This was helped by a 3rd consecutive year of good monsoons leading to high crop sowings during the year.

Coromandel showed a resilient performance with its diversified portfolio of Phosphatic Fertilizer, Single Super Phosphate, Crop Protection, Bio Pesticide, Specialized Nutrition including Organic fertiliser promoted balanced nutrition and integrated pest management with the help of its strong dealer network, nutriclinics and rural Retail centres.

 

The Company ensured the timely availability of critical agri-inputs including Fertilizer despite the tight raw material situation, leveraging its long-term contracts with the suppliers and backward integration. The Company has embarked upon a digital transformation journey which will help in further improving efficiency by using real-time data and analytics in decision making across the value chain. The Company continues to invest in Supply Chain, Manufacturing excellence, R&D, New product development, Digital marketing & Branding. During the year, the Government has worked closely with the industry on policy reforms and supported it through timely subsidy disbursement.

 

Healthy reservoir levels, good soil moisture conditions and forecast of a normal-monsoon augers well for Indian agriculture for the ensuing Kharif season. Coromandel will leverage its strong presence in the agri-inputs space and continue to work closely with the Government and the farming community to ensure availability and providing sustainable farming solutions to enhance farm productivity.”

Wednesday 27 April 2022

More days of savings with Joyalukkas

 More days of savings with Joyalukkas 'Incredible Flat 50%’ Offer extended till 27th March!


World’s favourite jeweller, Joyalukkas delightfully announces an extension to the ‘Incredible 50’ offer. This offer is seeing resounding success and to keep the spirits high, Joyalukkas is extending the offer period by another week. Customers can now enjoy a flat 50% off on making charges on all their favourite jewellery till 27th March. Gold prices in recent post-pandemic times have been fluctuating massively and ‘The Incredible 50 Offer’ brings customers an amazing opportunity to shop their favourite jewellery at attractive prices.

 

Announcing the extension of the offer period, Mr. Joy Alukkas, Chairman, Joyalukkas Group, quoted, “Joyalukkas is always delighted to present their customers with the best of offers and experience. Seeing how much the customers loved the ‘Incredible 50%’ offer, we decided to extend the offer period. Through this offer, we bring the most competitive rates in the market when it comes to making charges. Customers can enjoy a flat 50% discount on making charges for gold, diamond and other jewellery collections and save big when they shop with us. This also opens up an opportunity for customers to explore our high-end precious and exquisite jewellery, crafted by master artisans. Due to lowered making charges, these sophisticated jewellery collections are now more affordable. I would like to personally invite everyone to visit our showrooms and enjoy our limited period offer.”

 

You can enjoy this extended deal across all Joyalukkas showrooms in India till 27th March. In addition to The Incredible 50 offer, customers also get One Year Free Insurance and assured Lifetime Free Maintenance for all jewellery purchased from Joyalukkas and Gold Exchange offers.

Manipal Hospitals surpasses conventional recovery methods by

 Manipal Hospitals surpasses conventional recovery methods by 

obtaining the first ERAS certification in South East Asia

 

Manipal Hospitals has become the first healthcare provider in Southeast Asia to receive the ERAS (Enhanced recovery after surgery) certification. This programme offers enormous benefits to various healthcare fields, including Oncology, Gynaecology, and Gastroenterology. This is in line with the increasing application of technology in healthcare, which is helping doctors and multi-disciplinary surgeons widen their borders of study through evidence-based programs.

 

ERAS has helped multi-disciplinary surgeons of Manipal Hospitals achieve exceptional results in post-surgery care in their respective areas of healthcare – far ahead of the traditional post-surgery care in India. The wide range of benefits that the implementation of ERAS brings with it include decrease in complications, shorter length of stay at the hospital for the patient, decreased postoperative pain, and better and rapid recovery. These lead to early mobilisation of the patient post-surgery, and lesser chances of rehospitalisation.

 

Manipal Hospitals is the first in Southeast Asia to be certified for implementation of the ERAS programme. To receive this certification, multi-disciplinary surgeons, anesthesiologists, nurses, and nutritionists of the hospital underwent a comprehensive training programme where all the parameters were fulfilled. The medical team of Surgical Oncology, Gastrointestinal Surgery, Anesthesia and a team of Nurses, were trained by NCARE ERAS society in Switzerland and subsequently trained virtually through interactive seminars for over 2 years. The doctors certified for the programme include Dr. Somasekhar SP, Chairman and HOD Surgical Oncology, Manipal Comprehensive Cancer Center, Manipal Hospitals, Old Airport Road, Dr. Shabber Zaveri, Consultant - Surgical Oncology, Manipal Comprehensive Cancer Center, Dr. Ashwin Rajagopal, Consultant - Surgical Oncology, Manipal Comprehensive Cancer Center, Dr. Rohit Kumar, Consultant - Surgical Oncology, Dr. Nagaraj Palankar, Consultant - Surgical Gastroenterology and Dr. H S Murthy, Consultant - Anaesthesiology

 


 

 

The ERAS programme consists of three parameters; pre-operative optimisation, intraoperative gold directed therapy, and postoperative strategies. These parameters meticulously provide for patient/family preoperative counselling, optimization of nutrition and fluid intakes, minimal fasting with a carbohydrate beverage before anaesthesia, and other regimens. Post-surgery, the patient can return to a normal diet, achieving easy mobilization in the comfort of their homes, unlike in the case of traditional surgeries. The pilot programme was conducted for 507 patients.

 

ERAS benefits various spectrums of surgeries including colorectal, gynaecology, orthopaedic, pancreaticoduodenectomy, hepatectomy, gastrectomy, esophagectomy and oncology. The implementation of the ERAS programme was possible through the teamwork of Manipal Hospitals’ doctors and other staff.

 

Speaking on the initiative, Dr Somashekhar S P, Chairman & HOD Surgical Oncology - MHEPL Consultant Surgical & Gynaec Oncology & Robotic Surgeon, Hipec Super Specialist, Manipal Comprehensive Cancer Center, Old Airport Road, Bangalore, said, “The quality of ERAS translates into the best patient care across India. Along with clinical benefits, the days taken to recover are now shortened. Thus, patients can reduce their hospital stay and witness decreased postoperative pain. After implementation of ERAS, compliance rate rose from 36% to 94% in over 60% parameters in the application of ERAS. The rate of complications dropped down from 4.5% to 0.6%. Moreover, the length of stay in colorectal surgery reduced from 8 days to 4.5 days.

 

Speaking on the initiative, Mr. Deepak Venugopalan, Regional COO, Bengaluru Cluster, Mysuru & Salem, Manipal Hospitals, said, “ERAS has made it possible for Manipal Hospital’s surgeons to drive strategy-based concepts. This programme has been made possible due to the dedication shown by our multidisciplinary surgeons in undergoing the training for two years. We plan to implement ERAS in all units of Manipal Hospitals to give a big boost to post-surgery care.”